Inventor · disambiguated record
Bernd Kruss
Also filed as: KRUSS BERND
6 granted patents·6 pending applications·392 citations·filing 1987–2016
83Inventor score
Technology areasA61K
Files withBOEHRINGER INGELHEIM PHARMA6HENKE STEFAN2BOEHRINGER INGELHEIM VETMEDICA GMBH1MEDAC KLINISCHE SPEZIALPRAEP1THOMAE GMBH DR K1
Top patents by PatentIndex Score
12 records- 0194US5858410APharmaceutical nanosuspensions for medicament administration as systems with increased saturation solubility and rate of solutionMEDAC KLINISCHE SPEZIALPRAEP·Filed 1995·Granted Jan 12, 1999·363 cites·57 claims
- 0276US6982256B2Tolerance of 4-(4-(2-pyrrolylcarbonyl)-1-piperazinyl)-3-trifluoromethyl-benzoylguanidine in intravenous administrationBOEHRINGER INGELHEIM PHARMA·Filed 2002·Granted Jan 3, 2006·13 cites·16 claims
- 0374US9993557B2Highly concentrated stable meloxicam solutionsHENKE STEFAN·Filed 2005·Granted Jun 12, 2018·1 cites·3 claims
- 0463US6828311B2Formulation for the parenteral application of a sodium channel blockerBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted Dec 7, 2004·1 cites·29 claims
- 0561US9956288B2Highly concentrated stable meloxicam solutionsBOEHRINGER INGELHEIM VETMEDICA GMBH·Filed 2016·Granted May 1, 2018·0 cites·4 claims
- 0660US2006193786A1Pharmaceutical composition for intranasal administration containing a CGRP antagonistBOEHRINGER INGELHEIM PHARMA·Filed 2006·Application pending·0 cites
- 0760US2013178467A1Highly concentrated stable meloxicam solutionsHENKE STEFAN·Filed 2013·Application pending·0 cites
- 0856US2004076587A1Pharmaceutical composition for intranasal administration containing a CGRP antagonistBOEHRINGER INGELHEIM PHARMA·Filed 2003·Application pending·0 cites
- 0953US2006035862A1Tolerance of 4-(4-(2-pyrrolycarbonyl)-1-piperazinyl)-3-trifluoromethyl-benzoylguanidine in intravenous administrationBOEHRINGER INGELHEIM PHARMA·Filed 2005·Application pending·0 cites
- 1050US2004019075A1New formulation for the parenteral application of crobenetineBOEHRINGER INGELHEIM PHARMA·Filed 2003·Application pending·0 cites
- 1149US2002035107A1Highly concentrated stable meloxicam solutionsFiled 2001·Application pending·0 cites
- 1247US4824674AStable alpha-interferon dosage formsTHOMAE GMBH DR K·Filed 1987·Granted Apr 25, 1989·14 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Bernd Kruss files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →